Statins in the Primary, Secondary and Tertiary Prevention of Ischemic Stroke

Authors

  • Máximo Martin Roiz Balaguer Hospital Clínico-Quirúrgico Docente “Julio Trigo López” https://orcid.org/0000-0001-7876-5044
  • Ileana Morales Barrabia Hospital Clínico-Quirúrgico Docente “Julio Trigo López”

Keywords:

statins, primary prevention, secondary and tertiary, ischemic stroke, complications, mortality.

Abstract

Introduction: Ischemic stroke represents the third cause of mortality worldwide and the first cause of disability.

Objective: To describe the beneficial effects of the prescription of statins in the primary, secondary and tertiary prevention of ischemic stroke.

Methods: A bibliographic review on the prescription of statins in the primary, secondary and tertiary prevention of ischemic stroke was carried out. More than 400 articles published in MEDLINE/PubMed and Cochrane were reviewed. Only 50 articles met the selection criteria, which were published from May 2021 to June 2022.

Conclusions: The use of statins decreases mortality in primary and secondary prevention. If they are used early in the acute phase (tertiary prevention), the infarcted area decreases, there is clinical improvement and acute phase reactants such as C-reactive protein decrease.


Downloads

Download data is not yet available.

Author Biographies

Máximo Martin Roiz Balaguer, Hospital Clínico-Quirúrgico Docente “Julio Trigo López”

https://orcid.org/0000-0002-1402-1318

Especialista de Segundo grado en Medicina Interna, Máster en Longevidad Satisfactoria, Profesor Auxiliar.

Ileana Morales Barrabia, Hospital Clínico-Quirúrgico Docente “Julio Trigo López”

https://orcid.org/0000-0001-7316-3092

Especialista de primer grado en Medicina Interna, Máster en Longevidad Satisfactoria, Profesora Auxiliar.

Downloads

Published

2023-10-03

How to Cite

1.
Roiz Balaguer MM, Morales Barrabia I. Statins in the Primary, Secondary and Tertiary Prevention of Ischemic Stroke. Rev Cubana Med [Internet]. 2023 Oct. 3 [cited 2025 Mar. 12];62(4). Available from: https://revmedicina.sld.cu/index.php/med/article/view/3380

Issue

Vol. 62 No. 4 (2023): octubre-diciembre

Section

Review articles

License

The Cuban Journal of Medicine protects the author's patrimonial rights. However, it is licensed under a Creative Commons Licensehttps://creativecommons.org/licenses/by-nc/4.0/deed.es_ES which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is duly cited. The author always retains his moral rights.

 

You are free to:

- Share - copy and redistribute the material in any medium or format.

- Adapt - remix, transform and build upon the material

- The license cannot revoke these freedoms as long as you follow the terms of the license.

Under the following terms:

- Attribution - You must give proper credit, provide a link to the license, and indicate if changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is supported by the licensor.

- Non-Commercial Purpose- You may not make use of the material for commercial purposes.

- No Additional Restrictions - You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.